Live Verdure Ltd - Asset Resilience Ratio
Live Verdure Ltd (LV1) has an Asset Resilience Ratio of 0.03% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Live Verdure Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2022)
This chart shows how Live Verdure Ltd's Asset Resilience Ratio has changed over time. See Live Verdure Ltd (LV1) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Live Verdure Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Live Verdure Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$1.10K | 0.03% |
| Total Liquid Assets | AU$1.10K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Live Verdure Ltd maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Live Verdure Ltd Industry Peers by Asset Resilience Ratio
Compare Live Verdure Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Bausch Health Companies Inc
TO:BHC |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.15% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Hainan Haiyao Co Ltd
SHE:000566 |
Drug Manufacturers - Specialty & Generic | 3.27% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Live Verdure Ltd (2020–2022)
The table below shows the annual Asset Resilience Ratio data for Live Verdure Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.17% | AU$4.18K ≈ $2.96K |
AU$2.49 Million ≈ $1.76 Million |
+0.08pp |
| 2021-12-31 | 0.09% | AU$1.10K ≈ $778.32 |
AU$1.29 Million ≈ $909.75K |
+0.06pp |
| 2020-12-31 | 0.03% | AU$1.10K ≈ $778.32 |
AU$4.17 Million ≈ $2.95 Million |
-- |
About Live Verdure Ltd
Decidr AI Industries Ltd operates as an agentic AI-enablement company. It offers AI-driven automation for marketing, administration, finance, project management, and more. The company was formerly known as Live Verdure Limited and changed its name to Decidr AI Industries Ltd in March 2025. Decidr AI Industries Ltd was incorporated in 2016 and is based in Sydney, Australia.